FRED HUTCHINSON CANCER CENTER
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Myeloblastic Leukemia Without Maturation (M1)Adult Pure Erythroid Leukemia (M6b)Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Previously Treated Myelodysplastic SyndromesAdult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloid Leukemia With Del(5q)
- Interventions
- First Posted Date
- 2010-11-05
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT01235572
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMyelodysplastic SyndromeRecurrent Plasma Cell MyelomaChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaRefractory Chronic Lymphocytic LeukemiaWaldenstrom MacroglobulinemiaAggressive Non-Hodgkin LymphomaRefractory Chronic Myelogenous Leukemia, BCR-ABL1 PositiveSmall Lymphocytic Lymphoma
- Interventions
- First Posted Date
- 2010-11-01
- Last Posted Date
- 2019-10-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 174
- Registration Number
- NCT01231412
- Locations
- 🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States
🇺🇸VA Puget Sound Health Care System, Seattle, Washington, United States
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
- Conditions
- First Posted Date
- 2010-09-21
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 911
- Registration Number
- NCT01206309
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation
- Conditions
- Interventions
- First Posted Date
- 2010-08-10
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 355
- Registration Number
- NCT01178892
- Locations
- 🇺🇸
Kaiser Division of Research, Oakland, California, United States
🇺🇸Indiana University, Indianapolis, Indiana, United States
🇺🇸Group Health Research Institute, Seattle, Washington, United States
WebQuit Online Smoking Cessation Study
- Conditions
- Interventions
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 721
- Registration Number
- NCT01166334
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT01141959
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Untreated Adult Acute Myeloid Leukemiade Novo Myelodysplastic SyndromesMyelodysplastic Syndrome With Isolated Del(5q)
- Interventions
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 39
- Registration Number
- NCT01141725
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
- Conditions
- Interventions
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 854
- Registration Number
- NCT01121640
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸City of Hope, Duarte, California, United States
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma
- Conditions
- Interventions
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2011-12-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT01106235
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
- Conditions
- Interventions
- First Posted Date
- 2010-04-01
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT01097057
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States